Compare SFBC & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SFBC | RCEL |
|---|---|---|
| Founded | 1953 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 103.7M | 102.5M |
| IPO Year | N/A | N/A |
| Metric | SFBC | RCEL |
|---|---|---|
| Price | $43.57 | $3.28 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $8.67 |
| AVG Volume (30 Days) | 6.7K | ★ 202.3K |
| Earning Date | 01-28-2026 | 02-12-2026 |
| Dividend Yield | ★ 1.76% | N/A |
| EPS Growth | ★ 74.62 | N/A |
| EPS | ★ 2.65 | N/A |
| Revenue | $38,709,000.00 | ★ $72,401,000.00 |
| Revenue This Year | N/A | $13.12 |
| Revenue Next Year | N/A | $27.56 |
| P/E Ratio | $16.28 | ★ N/A |
| Revenue Growth | 10.38 | ★ 20.59 |
| 52 Week Low | $42.75 | $3.22 |
| 52 Week High | $55.00 | $14.16 |
| Indicator | SFBC | RCEL |
|---|---|---|
| Relative Strength Index (RSI) | 42.97 | 34.47 |
| Support Level | $43.11 | $3.22 |
| Resistance Level | $43.70 | $3.61 |
| Average True Range (ATR) | 0.43 | 0.18 |
| MACD | -0.02 | 0.01 |
| Stochastic Oscillator | 32.73 | 12.24 |
Sound Financial Bancorp Inc operates as the holding company for Sound Community Bank that provides traditional banking and other financial services for individuals and businesses. It attracts retail and commercial deposits from the public and invests those funds, along with borrowed funds, in loans secured by first and second mortgages on one-to-four-family residences including home equity loans and lines of credit, commercial and multifamily real estate, construction and land, consumer and commercial business loans. The bank also offers secured and unsecured consumer loan products, including manufactured home loans, floating home loans, automobile loans, boat loans, and recreational vehicle loans.
Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in rollout across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.